Mr. James Howard-Tripp reports

STAGEZERO LIFE SCIENCES' CLINICAL BUSINESS INTRODUCES THIRD PILLAR TO CANCER OFFERINGS

Stagezero Life Sciences Ltd.'s clinical business, Care Oncology, has added the first of a series of new program offerings. The Source functional nutrition group will provide educational sessions, live cooking lessons, biweekly drop-in cafes and 1:1 consultation, as well as a library of recipes and videos. The program initiates Friday, Oct. 27.

Screening to find cancer early is the first pillar (Aristotle); adjunctive treatment with the Care Oncology protocol is the second; nutritional guidance tailored to the type and stage of the cancer is the third pillar.

"Twenty-five per cent to 80 per cent of cancer patients, depending on their age, and the type and stage of the cancer, suffer from malnutrition. This problem has become much more acute since the COVID pandemic, as treatment options were delayed and access curtailed. Chemotherapy patients, especially, rely on oncology nutrition to help with physical strength and assistance during treatment. Nutritional screening and evaluation, as well as detailed nutritional guidance, are essential to assist with a good outcome," said James Howard-Tripp, chairman and chief executive officer of Stagezero Life Sciences. "We're really pleased to be partnering with The Source to offer a very comprehensive nutritional program that meets the needs of our current and future patient base," he added.

The American Cancer Society estimates the oncology nutrition market at $2.07-billion in 2023 and growing to $4.87-billion by 2033 (source: Future Market Insights oncology nutrition market report 2023).

The Source functional nutritional offering provides cancer-specific nutritional guidance with group information sessions, cooking lessons and one-on-one sessions. Diet is key to supporting a patient's ability to manage treatment and retain strength. Dietary guidance can differ between cancer type and stage of treatment. The Source program will show participants how to navigate this with concrete tools and recipes.

The program will be offered virtually out of the New Mexico Cancer Center. Each session will include an educational component as well as a cooking lesson. The first session will be focused on breast cancer and its unique nutritional needs. Additional, cancer-specific sessions will be offered regularly. The program is open to anyone, not just Care Oncology patients. Interested individuals can sign up at the Care Oncology website.

Additional resources and supports such as access to videos, recipes and nutrition cafe drop-in sessions, will be made available to participants. Participants will pay directly for each session. Subscription packages will follow by year-end.

Care Oncology offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Care Oncology has been treating cancer patients since 2013 using its patented COC Protocol. It is an individualized therapeutic approach which seeks to simultaneously target multiple metabolic cancer pathways and is intended for adjunctive administration alongside standard-of-care cancer therapy. The aim is to restrict cancer cell energy supply and use.

In addition to the COC Protocol, Care Oncology offers the AVRT program. All of the Care Oncology programs are managed by a multidisciplinary team that is overseen by an oncologist, and includes nurse practitioners and metabolic specialists.

About Stagezero Life Sciences Ltd.

Stagezero Life Sciences is a company innovating on the forefront of screening for the early detection of cancer. Stagezero combines its proprietary liquid biopsy multicancer detection test, Aristotle, with physician-led clinical programs -- offering patients a unique treatment combination not found anywhere else.

Aristotle is the first-ever mRNA multicancer panel for simultaneously screening for multiple cancers from a single sample of blood, with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types.

Care Oncology clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. It is an individualized therapeutic approach which seeks to simultaneously target multiple metabolic cancer pathways and is intended for adjunctive administration alongside standard-of-care cancer therapy. The aim is to restrict cancer cell energy supply and use.

The COC Protocol program is managed by a multidisciplinary team that is overseen by an oncologist, and includes nurse practitioners and metabolic specialists.

Care Oncology clinics also offers AVRT, a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease.

Aristotle is processed at the company's clinical laboratory, Stagezero Life Sciences Inc., a CAP-accredited and CLIA-certified high-complexity reference laboratory in Richmond, Va.

We seek Safe Harbor.